Watch a 23-minute medical lecture from Dana-Farber Cancer Institute where Dr. Adam Sperling explores the latest developments in CAR T-cell therapy for treating multiple myeloma. Gain insights into BCMA-targeted CAR T therapies and discover emerging therapeutic approaches targeting alternative pathways. Understand how this innovative immunotherapy is revolutionizing multiple myeloma treatment through detailed explanations from a leading expert in hematologic oncology.
CAR T-Cell Therapy for Multiple Myeloma Treatment and New Therapeutic Approaches
Dana-Farber Cancer Institute via YouTube
Overview
Syllabus
CAR T Cells in Multiple Myeloma
Taught by
Dana-Farber Cancer Institute
Related Courses
-
CAR T-Cell Therapy Advances and Treatments for Multiple Myeloma
-
免疫基因治疗
-
Bispecific Antibody Therapy for Treating Relapsed and Refractory Multiple Myeloma
-
Early Detection and Prevention of Multiple Myeloma Progression
-
Future of Novel Next-Generation Therapy in the Management of Relapsed/Refractory Multiple Myeloma
-
Bispecific Antibodies in Multiple Myeloma
